Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | renin | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Plasmodium falciparum | plasmepsin X | renin | 406 aa | 352 aa | 26.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | P2X receptor subunit | 0.0143 | 0.2769 | 0.2769 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0059 | 0.0968 | 0.0949 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0059 | 0.0968 | 0.0968 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0021 | 0.022 |
Plasmodium falciparum | plasmepsin II | 0.0059 | 0.0968 | 0.0968 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0143 | 0.2769 | 0.2754 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0015 | 0.0019 | 0.0201 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0015 | 0.0019 | 0.0201 |
Plasmodium vivax | plasmepsin IV, putative | 0.0059 | 0.0968 | 0.0968 |
Plasmodium falciparum | plasmepsin VI | 0.0059 | 0.0968 | 0.0968 |
Plasmodium vivax | delta-aminolevulinic acid dehydratase, putative | 0.0479 | 1 | 1 |
Onchocerca volvulus | 0.0014 | 0 | 0.5 | |
Leishmania major | cytochrome p450-like protein | 0.0015 | 0.0019 | 0.5 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0059 | 0.0968 | 0.0949 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0059 | 0.0968 | 0.0968 |
Onchocerca volvulus | 0.0014 | 0 | 0.5 | |
Brugia malayi | Cytochrome P450 family protein | 0.0015 | 0.0019 | 0.4502 |
Echinococcus multilocularis | delta aminolevulinic acid dehydratase | 0.0479 | 1 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.0015 | 0.0021 | 0.0021 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0016 | 0.0043 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0143 | 0.2769 | 0.2754 |
Schistosoma mansoni | porphobilinogen synthase | 0.0479 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0143 | 0.2769 | 0.2769 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0059 | 0.0968 | 0.0968 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0143 | 0.2769 | 0.2754 |
Wolbachia endosymbiont of Brugia malayi | delta-aminolevulinic acid dehydratase | 0.0479 | 1 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0059 | 0.0968 | 0.0968 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0968 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0015 | 0.0019 | 0.4502 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0016 | 0.0043 | 0.0447 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0143 | 0.2769 | 0.2754 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0015 | 0.0019 | 0.5 |
Trypanosoma brucei | cytochrome P450, putative | 0.0015 | 0.0019 | 0.5 |
Plasmodium falciparum | plasmepsin IV | 0.0059 | 0.0968 | 0.0968 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0015 | 0.0019 | 0.0201 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0059 | 0.0968 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0021 | 0.022 |
Schistosoma mansoni | P2X receptor subunit | 0.0143 | 0.2769 | 0.2769 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0174 | 0.344 | 0.344 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0174 | 0.344 | 0.344 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0021 | 0.022 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0143 | 0.2769 | 0.2754 |
Mycobacterium leprae | PROBABLE DELTA-AMINOLEVULINIC ACID DEHYDRATASE HEMB (PORPHOBILINOGEN SYNTHASE) (ALAD) (ALADH) | 0.0479 | 1 | 0.5 |
Toxoplasma gondii | parasite porphobilinogen synthase PBGS | 0.0479 | 1 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0143 | 0.2769 | 0.2754 |
Mycobacterium tuberculosis | Probable delta-aminolevulinic acid dehydratase HemB (porphobilinogen synthase) (ALAD) (ALADH) | 0.0244 | 0.4945 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0015 | 0.0019 | 0.5 |
Plasmodium falciparum | plasmepsin I | 0.0059 | 0.0968 | 0.0968 |
Mycobacterium ulcerans | delta-aminolevulinic acid dehydratase | 0.0479 | 1 | 1 |
Echinococcus granulosus | delta aminolevulinic acid dehydratase | 0.0479 | 1 | 1 |
Schistosoma mansoni | porphobilinogen synthase | 0.0479 | 1 | 1 |
Plasmodium falciparum | porphobilinogen synthase | 0.0479 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0143 | 0.2769 | 0.2769 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0059 | 0.0968 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 150 nM | Inhibition of recombinant human renin using 9 DNP-Lys-His-Pro-Phe-His-Leu-Val-Ile-His-D,L-Amp as substrate after 3 hrs by Q-FRET assay in presence of buffer at pH 7.4 | ChEMBL. | 22071301 |
IC50 (binding) | = 1200 nM | Inhibition of recombinant human renin in human plasma using QXL520-Lys-His-Pro-Phe-His-Leu-Val-Ile-His-Lys-(5-FAM) as substrate preincubated for 10 mins before substrate addition measured after 1 hrs by Q-FRET assay | ChEMBL. | 22071301 |
IC50 (ADMET) | = 6 uM | Reversible inhibition of CYP3A4 | ChEMBL. | 22071301 |
Ki (binding) | = 20 uM | Inhibition of human ERG | ChEMBL. | 22071301 |
TDI (ADMET) | = 11 % | Time-dependent inhibition of CYP3A4 assessed as conversion of testosterone to 6-beta-hydroxytestosterone at 10 uM after 30 mins | ChEMBL. | 22071301 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.